磁共振灌注参数对静脉溶栓后出血转化的预测研究

摘要/Abstract

摘要：

目的明确磁共振成像（magnetic resonance imaging，MRI）灌注参数脑血流达峰时间（Tmax）是否能预测急性缺血性卒中静脉溶栓后脑实质出血（parenchymal hemorrhage，PH），并确定其最佳阈值。方法回顾性分析接受静脉溶栓治疗的急性缺血性卒中患者，依据欧洲协作急性卒中研究 Ⅱ(European Cooperative Acute Stroke Study Ⅱ，ECASS Ⅱ）标准在溶栓后24 h复查的MRI或计算机断层扫描（computed tomography，CT）影像上评估出血转化。受试者工作特征曲线（receiver operating characteristic curve，ROC）分析Tmax预测PH型出血的最佳阈值以及该阈值下的最佳预测体积，并用 Logistic回归分析PH型出血的独立预测因素。结果纳入分析112例患者，其中11例（9.8%）发生PH型出血转化。Tmax＞8 s为预测PH型出血的最佳阈值（曲线下面积=0.706，P =0.025），低灌注（Tmax＞8 s区）体积大于45 ml为PH型出血的独立预测因素，优势比（odds ratio，OR）=13.95，P =0.014；PH型出血组与无PH型出血组之间Tmax＞14 s体积、Tmax ＞14 s/Tmax＞8 s的比值均无统计学差异（P =0.064；P =0.74）。结论磁共振灌注参数Tmax＞8 s为预测急性缺血性卒中溶栓后PH型出血转化的最佳阈值；低灌注体积，而非低灌注严重程度，与PH型出血转化相关。

文章导读： 本文探讨了Tmax对溶栓后出血转化的预测能力，有助于指导更安全的溶栓实践。

关键词: 急性; 缺血性卒中; 出血转化; 脑血流达峰时间

Abstract:

Objective To test whether Tmax of magnetic resonance imaging (MRI) could predict cerebral parechymal hemorrhage (PH) after intravenous thrombolysis and then investigate its optimal threshold. Methods Acute ischemic stroke patients undergoing intravenous thrombolysis were retrospectively analyzed. Follow-up imaging of MRI or computed tomography (CT) within 24 hours was assessed for hemorrhagic transformation according to European Cooperative Acute Stroke Study (ECASS Ⅱ) system. The optimal threshold and the optimal volume of Tmax to predict PH were analyzed with receiver operating characteristic curve (ROC). The association of Tmax with PH was examined using Logistic regression. Results One hundred and twelve patients were analyzed, of whom 11 (9.8%) deveolped PH after thrombolysis. Tmax>8 s was the optimal threshold to predict PH (area under curve [AUC]=0.706, P =0.025). The volume >45 ml of hypoperfusion region (Tmax>8 s) was independently predictive of PH (P =0.014, odds ratio [OR]=13.95). There were no significant differences of the Tmax>14 s volumes or the ratio of Tmax>14 s/Tmax>8 s between PH group and non-PH group (P =0.064; P =0.74). Conclusion The MR perfusion parameter of Tmax>8 s was the optimal threshold to predict PH. Hypoperfusion volume, rather than hypoperfusion intensity, was associated with PH.

Key words: Acute; Ischemic stroke; Hemorrhagic transformation; Tmax

陈伟莉1，张圣2，张顺开1，楼敏2. 磁共振灌注参数对静脉溶栓后出血转化的预测研究[J]. 中国卒中杂志, 2014, 9(11): 899-904.

CHEN Wei-Li, ZHANG Sheng, ZHANG Shun-Kai, LOU Min.. Magnetic Resonance Perfusion Parameter to Predict Hemorrhagic Transformation after
Intravenous Thrombolysis[J]. Chinese Journal of Stroke, 2014, 9(11): 899-904.

参考文献

1 重组组织型纤溶酶原激活剂治疗缺血性卒中共识专

家组. 重组组织型纤溶酶原激活剂静脉溶栓治疗缺血

性卒中中国专家共识(2012版)[J]. 中华内科杂志, 2012,

51:1006-1010.

2 Larrue V, von Kummer R, Muller A, et al. Risk

factors for severe hemorrhagic transformation in

ischemic stroke patients treated with recombinant

tissue plasminogen activator - A secondary analysis

of the European-Australasian Acute Stroke Study

(ECASS II)[J]. Stroke, 2001, 32:438-441.

3 Campbell BCV, Christensen S, Butcher KS, et al.

Regional very low cerebral blood volume predicts

hemorrhagic transformation better than diffusionweighted

imaging volume and thresholded apparent

diffusion coefficient in acute ischemic stroke[J].

Stroke, 2010, 41:82-88.

4 Campbell BC, Christensen S, Parsons MW, et al.

Advanced imaging improves prediction of hemorrhage

after stroke thrombolysis[J]. Ann Neurol, 2013,

73:510-519.

5 Tanne D, Kasner SE, Demchuk AM, et al. Markers

of increased r isk of int racerebral hemor rhage

after intravenous recombinant tissue plasminogen

activator therapy for acute ischemic stroke in clinical

practice:The multicenter rt-PA acute stroke survey[J].

Circulation, 2002, 105:1679-1685.

6 Singer OC, Humpich MC, Fiehler J, et al. Risk

for symptomatic intracerebral hemorrhage after

thrombolysis assessed by diffusion-weighted magnetic

resonance imaging[J]. Ann Neurol, 2008, 63:52-60.

7 Kim JH, Bang OY, Liebeskind DS, et al. Impact

of ba seline t issue st at us (dif f usion-weighted

imaging lesion) versus perfusion status (severity of

hypoperfusion) on hemorrhagic transformation[J].

Stroke, 2010, 41:e135-e142.

8 Mly na sh M, La nsbe rg MG, De Si lva DA, e t

a l. Ref i n i ng the def i n it ion of the ma l ig nant

profile:insights from the DEFUSE-EPITHET pooled

data set[J]. Stroke, 2011, 42:1270-1275.

9 Yassi N, Parsons MW, Christensen S, et al. Prediction of poststroke hemorrhagic transformation using

computed tomography perfusion[J]. Stroke, 2013,

44:3039-3043.

10 林悦涵, 楼敏, 朱仁洋, 等. 多模式MRI指导缺血性脑

卒中静脉溶栓降低出血转化的研究[J]. 浙江大学学报

(医学版), 2012, 41:665-671.

11 中国高血压防治指南修订委员会. 2010中国高血压防

治指南[J]. 中国医学前沿杂志, 2011, 3:42-93.

12 Amer ican Diabetes Association. Standards of

medical care in diabetes-2011[J]. Diabetes care, 2011,

34:S11-S61.

13 Peters SAE, Huxley RR, Woodward M. Smoking as a

Risk Factor for Stroke in Women Compared With Men

A Systematic Review and Meta-analysis of 81 Cohorts,

Including 3980359 Individuals and 42401 Strokes[J].

Stroke, 2013, 44:2821-2828.

14 Maier CM, Hsieh L, Crandall T, et al. Evaluating

therapeutic targets for reperfusion-related brain

hemorrhage[J]. Ann Neurol, 2006, 59:929-938.

15 Albers GW, Thijs VN, Wechsler L, et al. Magnetic

resonance imaging profiles predict clinical response to

early reperfusion:the Diffusion and perfusion imaging

Evaluation For Understanding Stroke Evolution

(DEFUSE) study[J]. Ann Neurol, 2006, 60:508-517.

16 Olivot JM, Mlynash M, Inoue M, et al. Hypoperfusion

intensity ratio predicts infarct progression and

functional outcome in the DEFUSE 2 cohort[J].

Stroke, 2014, 45:1018-1023.

17 Mit ef f F, Lev i CR, Bat ema n GA, e t a l. The

i nde p e nde nt pr e d ic t ive ut i l it y of c omput e d

tomography angiographic collateral status in acute

ischaemic stroke[J]. Brain, 2009, 132:2231-2238.

18 Thomalla G, Sobesky J, Kohrmann M, et al. Two

tales:hemorrhagic transformation but not parenchymal

hemorrhage after thrombolysis is related to severity

and duration of ischemia:MRI study of acute stroke

patients treated with intravenous tissue plasminogen

activator within 6 hours[J]. Stroke, 2007, 38:313-318.

[1]	吴娱倩, 张玉梅, 范小伟, 王安心, 逄文斌. 运动想象-动觉治疗对缺血性卒中患者手功能康复效果的研究[J]. 中国卒中杂志, 2022, 17(12): 1366-1371.
[2]	伊珞, 周宏宇, 仇鑫, 李子孝, 王拥军. 动脉粥样硬化性疾病的DNA甲基化改变[J]. 中国卒中杂志, 2022, 17(11): 1163-1170.
[3]	王誉博, 李子孝, 王拥军. 表观遗传学与缺血性卒中后氧化应激的相关性研究进展[J]. 中国卒中杂志, 2022, 17(11): 1171-1177.
[4]	崔凌云, 仇鑫, 周宏宇, 李子孝, 王拥军. DNA甲基化与2型糖尿病的相关性研究进展[J]. 中国卒中杂志, 2022, 17(11): 1183-1188.
[5]	刘光亮, 韩凯月, 苏文龙, 张皓. 不同强度有氧踏车训练对不同病程缺血性卒中患者运动和心肺适能的影响 [J]. 中国卒中杂志, 2022, 17(11): 1203-1208.
[6]	徐莹鑫, 张爽, 周晓梅, 袁景林, 赵留庄, 杨海华. 非狭窄性颈动脉斑块与前循环不明原因栓塞性卒中的相关性研究 [J]. 中国卒中杂志, 2022, 17(11): 1233-1237.
[7]	程实, 李静, 郭军平, 胡爱香, 于鑫玮, 韩玮, 梁瑛, 张越巍, 冀瑞俊. 急性卒中患者住院期间感染的临床特征及危险因素分析[J]. 中国卒中杂志, 2022, 17(10): 1065-1070.
[8]	向薇, 徐璐瑶, 张曼曼, 魏红春, 梁志刚. 缺血性卒中急性期磁敏感加权成像不对称突出静脉征的发生率及影响因素分析[J]. 中国卒中杂志, 2022, 17(10): 1097-1102.
[9]	赵永瑞, 刘展会. 弥散张量成像在缺血性卒中患者运动功能预后评估中的研究进展[J]. 中国卒中杂志, 2022, 17(10): 1114-1119.
[10]	张伯煜, 郭玉成, 崔玉霞, 李英丽, 吕雨梅. 急性缺血性卒中患者就医行为决策现状及影响因素研究进展[J]. 中国卒中杂志, 2022, 17(10): 1127-1132.
[11]	吴亭亭, 刘亚飞, 闫世曦, 武一平, 张忠波, 张邯菲, 房娉平. “互联网+”在急性缺血性卒中救治中的应用进展[J]. 中国卒中杂志, 2022, 17(10): 1133-1138.
[12]	徐蔚海, 李顺, 程安琪. 青年卒中的诊治：勿过激[J]. 中国卒中杂志, 2022, 17(09): 915-918.
[13]	张一歌, 张婉, 张璐阳, 王鑫, 丁澜, 王玉莹, 裴璐璐, 方慧, 许予明, 宋波. 责任动脉闭塞与夹层相关缺血性卒中复发的相关性分析[J]. 中国卒中杂志, 2022, 17(09): 932-936.
[14]	吕微, 王安心, 田雪, 张晓丽, 许玉园, 孟霞. 心血宁胶囊对伴高同型半胱氨酸水平缺血性卒中患者短期功能预后的影响[J]. 中国卒中杂志, 2022, 17(09): 972-976.
[15]	张心邈, 潘岳松, 向祥龙, 王拥军, 孟霞. 早期临床路径干预改善卒中医疗服务质量关键绩效指标研究[J]. 中国卒中杂志, 2022, 17(09): 977-984.